Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: A report from the European Group for Blood and Marrow Transplantation (EBMT)

Bone Marrow Transplantation

Volumn 21, Issue 5, 1998, Pages 473-476

  Ljungman, P ^a   Cordonnier, C ^b   Einsele, H ^b   Bender Gotze C ^b   Bosi, A ^b   Dekker, A ^b   De La Camara, R ^b   Gmur J ^b   Newland, A C ^b   Prentice, H G ^b   Robinson, A J ^b   Rovira, M ^b   Rosler W ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

CMV; Ganciclovir; Gastrointestinal disease; Immune globulin

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0031885701     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701113     Document Type: Article

References (13)

1. Ljungman P, Engelhard D, Link H et al. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. Clin Infect Dis 1992; 14: 831-835.
2. Boeckh M, Gooley TA, Myerson D et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063-4071.
3. Enright H, Haake R, Weisdorf D et al. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation 1993; 55: 1339-1346.
4. Einsele H, Ehninger G, Steidle M et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993; 82: 1672-1678.
5. Emanuel D, Cunningham I, Jules EK et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777-782.
6. Reed EC, Bowden RA, Dandliker PS et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988; 109: 783-788.
7. Schmidt GM, Kovacs A, Zaia JA et al. Ganciclovir/ immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 1988; 46: 905-907.
8. Ljungman P, De Bock R, Cordonnier C et al. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant 1993; 12: 399-403.
9. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Plotkin ES, Michelson S (eds). Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Excerpta Medica International Congress Series: Amsterdam, 1993, vol. 1032, 233-240.
10. Reed EC, Wolford JL, Kopecky KJ et al. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med 1990; 112: 505-510.
11. Boeckh M, Riddell S, Cunningham T et al. Increased rate of late CMV infection and disease in allogeneic marrow transplant recipients after ganciclovir prophylaxis is due to a lack of CMV specific T cell responses. Blood 1996; 88 (Suppl. 1): 302A.
12. Meyers J, Flournoy N, Thomas E. Nonbacterial pneumonia after allogeneic marrow transplantation: review of ten years' experience. Rev Infect Dis 1982; 4: 1119-1131.
13. Meyers JD. Prevention and treatment of cytomegalovirus infection after marrow transplantation. Bone Marrow Transplant 1988; 3: 95-104.